老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ascendis Pharma A/S

216.95
-3.6500-1.65%
盘后：216.950.00000.00%19:04 EDT
成交量：58.08万
成交额：1.28亿
市值：135.19亿
市盈率：-49.11
高：223.91
开：220.68
低：216.03
收：220.60
52周最高：248.60
52周最低：124.06
股本：6,231.61万
流通股本：6,008.34万
量比：1.65
换手率：0.97%
股息：- -
股息率：- -
每股收益(TTM):-4.4176
每股收益(LYR):-4.4176
净资产收益率：-818.43%
总资产收益率：-6.86%
市净率：-71.93
市盈率(LYR):-49.11

数据加载中...

总览公司新闻资讯公告
2020/03/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/23

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
更多